PHRRF
Price
$0.15
Change
-$0.01 (-6.25%)
Updated
Dec 24 closing price
RLYB
Price
$0.86
Change
-$0.05 (-5.49%)
Updated
Dec 24 closing price
83 days until earnings call
Ad is loading...

PHRRF vs RLYB

Header iconPHRRF vs RLYB Comparison
Open Charts PHRRF vs RLYBBanner chart's image
PharmaTher Holdings
Price$0.15
Change-$0.01 (-6.25%)
Volume$11.3K
CapitalizationN/A
Rallybio
Price$0.86
Change-$0.05 (-5.49%)
Volume$359.44K
CapitalizationN/A
PHRRF vs RLYB Comparison Chart
Loading...
PHRRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHRRF vs. RLYB commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHRRF is a Hold and RLYB is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (PHRRF: $0.15 vs. RLYB: $0.86)
Brand notoriety: PHRRF and RLYB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHRRF: 3% vs. RLYB: 374%
Market capitalization -- PHRRF: $13.85M vs. RLYB: $35.56M
PHRRF [@Biotechnology] is valued at $13.85M. RLYB’s [@Biotechnology] market capitalization is $35.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHRRF’s FA Score shows that 0 FA rating(s) are green whileRLYB’s FA Score has 1 green FA rating(s).

  • PHRRF’s FA Score: 0 green, 5 red.
  • RLYB’s FA Score: 1 green, 4 red.
According to our system of comparison, RLYB is a better buy in the long-term than PHRRF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHRRF’s TA Score shows that 3 TA indicator(s) are bullish while RLYB’s TA Score has 4 bullish TA indicator(s).

  • PHRRF’s TA Score: 3 bullish, 7 bearish.
  • RLYB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RLYB is a better buy in the short-term than PHRRF.

Price Growth

PHRRF (@Biotechnology) experienced а -4.35% price change this week, while RLYB (@Biotechnology) price change was -16.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

RLYB is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLYB($35.6M) has a higher market cap than PHRRF($13.9M). PHRRF YTD gains are higher at: -35.438 vs. RLYB (-64.138). RLYB has more cash in the bank: 75.1M vs. PHRRF (1.9M).
PHRRFRLYBPHRRF / RLYB
Capitalization13.9M35.6M39%
EBITDAN/A-69.86M-
Gain YTD-35.438-64.13855%
P/E RatioN/AN/A-
RevenueN/A598K-
Total Cash1.9M75.1M3%
Total DebtN/A230K-
TECHNICAL ANALYSIS
Technical Analysis
PHRRFRLYB
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
88%
Bullish Trend 14 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
PHRRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTM0.580.15
+35.23%
Castellum
VNDA4.830.15
+3.21%
Vanda Pharmaceuticals
LVS51.890.23
+0.45%
Las Vegas Sands Corp
IDA110.450.33
+0.30%
IDACORP
JBSS83.77-1.03
-1.21%
John B Sanfilippo & Son

PHRRF and

Correlation & Price change

A.I.dvisor tells us that PHRRF and HOTH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHRRF and HOTH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHRRF
1D Price
Change %
PHRRF100%
-0.33%
HOTH - PHRRF
24%
Poorly correlated
-3.73%
RLYB - PHRRF
20%
Poorly correlated
-5.95%
INNMF - PHRRF
20%
Poorly correlated
N/A
ANTX - PHRRF
20%
Poorly correlated
-2.86%
KMSTF - PHRRF
13%
Poorly correlated
N/A
More

RLYB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with PXXLF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then PXXLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
-5.95%
PXXLF - RLYB
44%
Loosely correlated
N/A
CLYM - RLYB
42%
Loosely correlated
+3.13%
VERU - RLYB
35%
Loosely correlated
-2.87%
SEOVF - RLYB
34%
Loosely correlated
-0.33%
CRMD - RLYB
34%
Loosely correlated
-1.07%
More